Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment With Lithium

被引:8
作者
Calkin, Cynthia [1 ]
Alda, Martin [1 ]
机构
[1] Dalhousie Univ, Dept Psychiat, Halifax, NS B3H 2E2, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2012年 / 57卷 / 07期
关键词
bipolar disorder; lithium; mood stabilizer; ANXIETY TREATMENTS CANMAT; OPEN-LABEL TRIAL; II DISORDERS; ANTIDEPRESSANT TREATMENT; MAINTENANCE TREATMENT; BRITISH-ASSOCIATION; TREATMENT RESPONSE; SYMPTOMATIC STATUS; PATIENT SELECTION; ATYPICAL FEATURES;
D O I
10.1177/070674371205700707
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Several treatment guidelines are available for clinicians working with patients with bipolar disorder (BD), but some of the more nuanced aspects of lithium therapy go beyond the scope of such guidelines. Therefore, in this perspective, our objective was to focus on specific practical issues of lithium treatment, including the selection and initiation of long-term treatment, and management and discontinuation (if indicated) of lithium prophylaxis. Method: We conducted a focused review of the relevant literature on the treatment of BD. Results: Consultation requests to a BD specialty service often relate to issues for which there is limited evidence, including when to initiate long-term treatment, whether choice of mood stabilizer is specific, how long to treat acute episodes, whether to switch or add on medication when treatment fails, how long to continue effective treatment, and what medication to use when a lithium-responsive patient must discontinue lithium. Conclusion: Optimal long-term treatment of BD will require more research as well as better alignment of clinical and training programs.
引用
收藏
页码:437 / 445
页数:9
相关论文
共 91 条
[1]   Does lithium exert an independent antisuicidal effect? [J].
Ahrens, B ;
Müller-Oerlinghausen, B .
PHARMACOPSYCHIATRY, 2001, 34 (04) :132-136
[2]   EXCESS CARDIOVASCULAR AND SUICIDE MORTALITY OF AFFECTIVE-DISORDERS MAY BE REDUCED BY LITHIUM PROPHYLAXIS [J].
AHRENS, B ;
MULLEROERLINGHAUSEN, B ;
SCHOU, M ;
WOLF, T ;
ALDA, M ;
GROF, E ;
GROF, P ;
LENZ, G ;
SIMHANDL, C ;
THAU, K ;
VESTERGAARD, P ;
WOLF, R ;
MOLLER, HJ .
JOURNAL OF AFFECTIVE DISORDERS, 1995, 33 (02) :67-75
[3]  
AKISKAL HS, 1985, ARCH GEN PSYCHIAT, V42, P996
[4]  
AKISKAL HS, 1983, HOSP COMMUNITY PSYCH, V34, P695
[5]   Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder? [J].
Alda, Martin .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2009, 54 (11) :719-721
[6]   The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial [J].
Allan, SJR ;
Kavanagh, GM ;
Herd, RM ;
Savin, JA .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) :966-969
[7]   The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients [J].
Angst, J ;
Adolfsson, R ;
Benazzi, F ;
Gamma, A ;
Hantouche, E ;
Meyer, TD ;
Skeppar, P ;
Vieta, E ;
Scott, J .
JOURNAL OF AFFECTIVE DISORDERS, 2005, 88 (02) :217-233
[8]   Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions [J].
Angst, J ;
Sellaro, R ;
Stassen, HH ;
Gamma, A .
JOURNAL OF AFFECTIVE DISORDERS, 2005, 84 (2-3) :149-157
[9]  
[Anonymous], 1985, Am J Psychiatry, V142, P469
[10]  
BAASTRUP PC, 1967, ARCH GEN PSYCHIAT, V16, P162